SURV1VE试验:持续充气联合胸外按压与3:1按压通气比在窒息新生儿复苏中的比较——整群随机对照试验研究方案
SURV1VE试验是一项国际多中心、前瞻性、非盲法整群随机对照试验,纳入胎龄>28+0周、出生时因心动过缓(<60/min)或心搏停止需心肺复苏的窒息新生儿,比较持续充气联合胸外按压(CC+SI)与3:1按压通气比(90次/分按压+30次/分通气)的复苏策略,主要结局为恢复自主循环(ROSC)时间。
要点
- SURV1VE试验首次在产房比较CC+SI与3:1按压通气比用于窒息新生儿心肺复苏。
- 纳入标准为胎龄>28+0周、出生时心动过缓(<60/min)或心搏停止需心肺复苏的新生儿。
- 主要结局为恢复自主循环(ROSC)时间,试验注册号NCT02858583。
核心结论
- SURV1VE试验旨在比较持续充气联合胸外按压(CC+SI)与3:1按压通气比在窒息新生儿心肺复苏中对恢复自主循环时间的影响。
研究设计与样本
- 国际多中心、前瞻性、非盲法、整群随机对照试验,纳入胎龄>28+0周、出生时因心动过缓(<60/min)或心搏停止需心肺复苏的窒息新生儿。
- 试验注册于ClinicalTrials.gov,注册号NCT02858583,注册日期2016年8月8日。
关键数值与推荐
- 当前新生儿复苏指南推荐使用协调的3:1按压通气比(按压90次/分,通气30次/分)。
- 纳入标准:胎龄>28+0周(根据最佳产科估计),出生时心动过缓(<60/min)或心搏停止需心肺复苏。
- 主要结局:比较接受CC+SI或3:1按压通气比复苏策略的婴儿恢复自主循环(ROSC)时间。
临床怎么用
- 该试验将为产房窒息新生儿心肺复苏中胸外按压方式的选择提供随机对照证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The need for cardiopulmonary resuscitation (CPR) is often unexpected, and the infrequent use of CPR in the delivery room (DR) limits the opportunity to perform rigorous clinical studies to determine the best method for delivering chest compression (CC) to newborn infants. The current neonatal resuscitation guidelines recommend using a coordinated 3:1 compression-to-ventilation (C:V) ratio (CC at a rate of 90/min and ventilations at a rate of 30/min). In comparison, providing CC during a sustained inflation (SI) (CC + SI) significantly improved hemodynamics, minute ventilation, and time to return of spontaneous circulation (ROSC) compared to 3:1 C:V ratio in asphyxiated piglets. Similarly, a small pilot trial in newborn infants showed similar results. Until now no study has examined different CC techniques during neonatal resuscitation in asphyxiated newborn infants in the DR. To date, no trial has been performed to directly compare CC + SI and 3:1 C:V ratio in the DR during CPR of asphyxiated newborn infants. METHODS: This is a large, international, multi-center, prospective, unblinded, cluster randomized controlled trial in asphyxiated newborn infants at birth. All term and preterm infants > 28+ 0 by best obstetrical estimate who require CPR at birth due to bradycardia (< 60/min) or asystole are eligible. The primary outcome of this study is to compare the time to ROSC in infants born > 28+ 0 weeks' gestational age with bradycardia (< 60/min) or asystole immediately after birth who receive either CC + SI or 3:1 C:V ratio as the CPR strategy. DISCUSSION: Morbidity and mortality rates are extremely high for newborns requiring CC. We believe the combination of simultaneous CC and SI during CPR has the potential to significantly improve ROSC and survival. In addition, we believe that CC + SI might improve respiratory and hemodynamic parameters and potentially minimize morbidity and mortality in newborn infants. In addition, this will be the first randomized controlled trial to examine CC in the newborn period. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02858583 . Registered on 8 August 2016.
引用
- Schmölzer GM, Pichler G, Solevåg AL, et al. The SURV1VE trial-sustained inflation and chest compression versus 3:1 chest compression-to-ventilation ratio during cardiopulmonary resuscitation of asphyxiated newborns: study protocol for a cluster randomized controlled trial. Trials. 2019. PMID: 30782199. doi:10.1186/s13063-019-3240-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。